Cutaneous immunological activation elicited by a low-fluence pulsed dye laser

Area of Science:

• Dermatology
• Immunology
• Laser Medicine

Background:

• The 585-nm visible light laser (Chromogenex V3) is used for nonablative wrinkle reduction, acne, and atopic dermatitis.
• Previous reports suggest the Chromogenex V3 laser may have immunological functions.
• This study investigates laser-induced immunological changes at the ultrastructural level and via cytokine mRNA analysis.

Purpose of the Study:

• To investigate ultrastructural immunological changes in the skin after 585-nm laser irradiation.
• To analyze the expression of interleukin (IL)-2 and IL-4 messenger RNA (mRNA) in skin-homing T lymphocytes post-laser treatment.

Main Methods:

• Eight healthy volunteers received 585-nm laser treatment.
• Skin biopsies were analyzed ultrastructurally at multiple time points up to 5 weeks post-treatment.
• Interleukin (IL)-2 and IL-4 mRNA levels in T cells were quantified using reverse transcriptase-polymerase chain reaction.

Main Results:

• Ultrastructural analysis revealed acute inflammatory changes with neutrophils, monocytes, and mast cells appearing within 3 hours and persisting for 1 week.
• Lymphocytes and fibroblasts increased significantly by 4-5 weeks post-laser treatment.
• All subjects showed elevated IL-2 and IL-4 mRNA levels one week after treatment, with IL-4 mRNA being more abundant than IL-2 mRNA.

Conclusions:

• The 585-nm visible light laser (Chromogenex V3) influences skin immunity.
• Laser treatment may induce direct cutaneous immunological activation in addition to selective photothermolysis.
• The findings support a role for the Chromogenex V3 laser in modulating skin immune responses.